Complications and Supportive Care
The complications associated with neoplastic disease are usually the result of the disease process itself or are secondary to therapy. Supportive measures for the patient with cancer are often the major focus of care. Such measures can be important, particularly when a cost/benefit assessment of specific cancer-directed therapy suggests that treatment is not warranted. At these times, it is often psychologically optimal for the patient to view his or her illness as chronic, and therefore incurable, but not beyond supportive measures. In such situations, the complexity of medical intervention should be defined in the context of the patient’s disease progression. Obviously, quality of life issues become the focal points in this decision-making process. Individualization of treatment and supportive care is critical.
KeywordsFatigue Sarcoma Neutropenia Meningitis Thrombocytopenia
Unable to display preview. Download preview PDF.
- Calabresi P, Schein PS, Rosenberg SA (eds) (1985) Medical oncology: basic principles and clinical management of cancer. MacMillan, New York, pp 1261–1522Google Scholar
- DeVita VT, Hellman S, Rosenberg S (eds) (1993) Cancer–principles and practice of oncology, 4th edn. Lippincott, Philadelphia, pp 2262–2337Google Scholar
- Lieschke GJ, Burgess AW (1992) Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor. New England Journal of Medicine 327:28–35, 99–106Google Scholar